Brazil’s health regulator is facing political backlash after suspending final-stage trials of a Chinese-made coronavirus vaccine following an event that scientists involved in the study said was unrelated to the testing.
Late on Monday, Anvisa said that a CoronaVac trial of 9,000 people had been halted due to an “adverse event” on October 29. The trial was carried out jointly with São Paulo’s Butantan Institute, a biomedical research centre.
But on Tuesday the institute questioned why the trial had been halted, saying the event had no relation to the vaccine.
您已阅读12%（563字），剩余88%（4137字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。